Clinical Trials Directory

Trials / Completed

CompletedNCT05319470

Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Democritus University of Thrace · Academic / Other
Sex
All
Age
35 Years – 90 Years
Healthy volunteers

Summary

Primary objective of this study is to study the efficacy of travoprost without preservatives in the treatment of glaucoma patients and to monitor the ocular surface.

Detailed description

This is a prospective study including patients visiting the outpatient glaucoma clinic of the University General Hospital of Alexandroupolis for their standard evaluation. Study population is already under treatment with a travoprost preparation without preservatives. They will be fully informed about the procedure and the purpose of the study and a written consent will be obtained. For every patient included in the study intraocular pressure will be measured using a Goldman applanation tonometer, according to the standard way of practice at our clinic. Also, Tear Break-Up-Time (BUT), conjunctival hyperemia grading and Schirmer testing will be used to assess the ocular surface state. Visual field tests and OCT RNFL measurements will also be obtained. The above measurements will be repeated 6 months after the initial examination.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTIntraocular pressure (IOP)Measurement of intraocular pressure in both eyes of the study population using the Goldman applanation tonometer.
DIAGNOSTIC_TESTTear Break-up Time (TBUT)TBUT will be calculated after instillation of a drop of fluorescein dye, by slit lamp biomicroscopy.
DIAGNOSTIC_TESTConjuctival HyperemiaConjunctival hyperemia will be assessed by slit lamp biomicroscopy using a validated grading system.
DIAGNOSTIC_TESTSchirmer TestSchirmer test will be performed on both eyes to asses tear production.
DIAGNOSTIC_TESTVisual Fields and OCT RNFLVisual field examination using a Humphrey perimeter and measurement of peripapillary retinal nerve fiber layer thickness with optical coherence tomography.

Timeline

Start date
2022-03-15
Primary completion
2023-04-15
Completion
2023-05-15
First posted
2022-04-08
Last updated
2023-07-05

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT05319470. Inclusion in this directory is not an endorsement.